Clinical Trial Update: Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating three regimens of PegIntron (pegylated interferon alfa-2b) plus ribavirin in treatment-naïve adults with chronic hepatitis C genotype 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2009-08-11